索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]邱原,张昊,梁兆光.射频消融术治疗持续性心房颤动的评价[J].国际心血管病杂志,2023,01:34-37.
点击复制

射频消融术治疗持续性心房颤动的评价(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2023年01期
页码:
34-37
栏目:
综述
出版日期:
2023-01-20

文章信息/Info

Title:
-
作者:
邱原; 张昊; 梁兆光
150000 哈尔滨医科大学研究生院（邱原）；150000 哈 尔滨医科大学附属第一医院心血管内科病房（梁兆光）
Author(s):
-
关键词:
持续性心房颤动; 射频消融; 疗效评价
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2023.01.009
文献标识码:
-
摘要:
肺静脉隔离是心房颤动（房颤）消融策略的基石，也是阵发性房颤射频消融的 主流术式，但对于持续性房颤患者，肺静脉隔离疗效仍显不足。随着消融治疗等相关技术不 断提高，房颤射频消融术式也呈现多样性。该文介绍目前持续性房颤射频消融的术式及疗效， 以期为房颤消融策略的选择提供临床依据。
Abstract:
-

参考文献/References

[1] Ponamgi SP, Siontis KC, Rushlow DR, et al. Screening and management of atrial fibrillation in primary care[J]. BMJ, 2021, 373:n379.
[2] Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC[J]. Eur Heart J, 2021, 42(5):373-498.
[3] Clarnette JA, Brooks AG, Mahajan R, et al. Outcomes of persistent and long-standing persistent atrial fibrillation ablation: a systematic review and meta-analysis[J]. Europace, 2018, 20(FI_3):f366-f376.
[4] Sebag FA, Simeon E, Miled M, et al. Single-catheter simplified stepwise approach to persistent atrial fibrillation ablation: a feasibility study[J]. Arch Cardiovasc Dis, 2021, 114(11):707- 714.
[5] Lai Y, Liu X, Sang C, et al. Effectiveness of ethanol infusion into the vein of Marshall combined with a fixed anatomical ablation strategy (the "upgraded 2C3L" approach) for catheter ablation of persistent atrial fibrillation[J]. J Cardiovasc Electrophysiol, 2021, 32(7):1849-1856.
[6] Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation[J]. N Engl J Med, 2015, 372(19):1812-1822.
[7] Yoshida A, Takami KR, Yamada S, et al. Efficacy of complex fractionated atrial electrogram-guided extensive encircling pulmonary vein isolation for persistent atrial fibrillation[J]. Circ Rep, 2019, 1(5):206-211.
[8] Waranugraha Y, Rizal A, Setiawan D, et al. Additional complex fractionated atrial electrogram ablation does not improve the outcomes of non-paroxysmal atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials[J]. Indian Heart J, 2021, 73(1):63-73.
[9] Spittler R, Bahlke F, Hoffmann BA, et al. Durable pulmonary vein isolation but not complex substrate ablation determines the type of arrhythmia recurrence after persistent atrial fibrillation ablation[J]. J Interv Card Electrophysiol, 2022, 64(2):417-426.
[10] Thiyagarajah A, Kadhim K, Lau DH, et al. Feasibility, safety, and efficacy of posterior wall isolation during atrial fibrillation ablation: a systematic review and meta-analysis[J]. Circ Arrhythm Electrophysiol, 2019, 12(8):e007005.
[11] Garcia F, Enriquez A, Arroyo A, et al. Roof-dependent atrial flutter with an epicardial component: role of the septopulmonary bundle[J]. J Cardiovasc Electrophysiol, 2019, 30(7):1159-1163.
[12] DeLurgio DB, Crossen KJ, Gill J, et al. Hybrid convergent procedure for the treatment of persistent and long-standing persistent atrial fibrillation: results of CONVERGE clinical trial[J]. Circ Arrhythm Electrophysiol, 2020, 13(12):e009288.
[13] Lu XF, Peng S, Wu XY, et al. Anatomical insights into posterior wall isolation in patients with atrial fibrillation: a hypothesis to protect the esophagus[J]. J Cardiovasc Electrophysiol, 2021, 32(2):270-278.
[14] Yang G, Yang B, Wei YQ, et al. Catheter ablation of nonparoxysmal atrial fibrillation using electrophysiologically guided substrate modification during sinus rhythm after pulmonary vein isolation[J]. Circ Arrhythm Electrophysiol, 2016, 9(2):e003382.
[15] Efremidis M, Vlachos K, Letsas KP, et al. Targeted ablation of specific electrogram patterns in low-voltage areas after pulmonary vein antral isolation in persistent atrial fibrillation: termination to an organized rhythm reduces atrial fibrillation recurrence[J]. J Cardiovasc Electrophysiol, 2019, 30(1):47-57.
[16] Yamaji H, Higashiya S, Murakami T, et al. Efficacy of an adjunctive electrophysiological test-guided left atrial posterior wall isolation in persistent atrial fibrillation without a left atrial low-voltage area[J]. Circ Arrhythm Electrophysiol, 2020, 13(8):e008191.
[17] Hong KL, Glover BM. Ablation of low-voltage areas for persistent atrial fibrillation: procedural outcomes using highdensity voltage mapping[J]. Can J Cardiol, 2021, 37(8):1296.
[18] Valderrábano M, Peterson LE, Swarup V, et al. Effect of catheter ablation with vein of marshall ethanol infusion vs catheter ablation alone on persistent atrial fibrillation: the Venus randomized clinical trial[J]. JAMA, 2020, 324(16):1620-1628.
[19] Derval N, Duchateau J, Denis A, et al. Marshall bundle elimination, pulmonary vein isolation, and line completion for ANatomical ablation of persistent atrial fibrillation (Marshall- PLAN): prospective, single-center study[J]. Heart Rhythm, 2021, 18(4):529-537.
[20] Kamakura T, Derval N, Duchateau J, et al. Vein of marshall ethanol infusion: feasibility, pitfalls, and complications in over 700 patients[J]. Circ Arrhythm Electrophysiol, 2021, 14(8):e010001.
[21] Kirzner JM, Raelson CA, Liu CF, et al. Effects of focal impulse and rotor modulation-guided ablation on atrial arrhythmia termination and inducibility: impact on outcomes after treatment of persistent atrial fibrillation[J]. J Cardiovasc Electrophysiol, 2019, 30(12):2773-2781.
[22] Romero J, Gabr M, Alviz I, et al. Focal impulse and rotor modulation guided ablation versus pulmonary vein isolation for atrial fibrillation: a meta-analysis of head-to-head comparative studies[J]. J Cardiovasc Electrophysiol, 2021, 32(7):1822-1832.
[23] Hsieh YC, Lin YJ, Lo MT, et al. Optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3-year follow-up outcomes[J]. J Cardiovasc Electrophysiol, 2021, 32(6):1561-1571.
[24] Choi EK, Zhao Y, Everett TH, et al. Ganglionated plexi as neuromodulation targets for atrial fibrillation[J]. J Cardiovasc Electrophysiol, 2017, 28(12):1485-1491.
[25] Driessen AHG, Berger WR, Krul SPJ, et al. Ganglion plexus ablation in advanced atrial fibrillation: the AFACT study[J]. J Am Coll Cardiol, 2016, 68(11):1155-1165.
[26] Xu FQ, Yu RH, Guo JJ, et al. Catheter ablation of recurrent paroxysmal atrial fibrillation: is gap-closure combining ganglionated plexi ablation more effective?[J]. Pacing Clin Electrophysiol, 2017, 40(6):672-682.
[27] Zhou W, Chen JL, Chen JJ, et al. Study of the distribution of epicardial vagal ganglion and the relationship between delayed enhancement magnetic resonance imaging and radiofrequency ablation in patients with atrial fibrillation[J]. World Neurosurg, 2020, 138:732-739.
[28] Ma N, Ding SA, Zeng LJ, et al. Immediate electrophysiological characteristics following modified thoracoscopic ablation via unilateral approach for non-valvular atrial fibrillation[J]. Heart Vessels, 2021, 36(6):874-881.

备注/Memo

备注/Memo:
通信作者：梁兆光， E-mail：1294158735@qq.com
更新日期/Last Update: 2023-01-20